Company Filing History:
1 out of 17 
1 out of 24 Years Active: 2015-2018
Title: The Innovative Contributions of Ricardo Tostes Gazzinelli
Introduction
Ricardo Tostes Gazzinelli is a prominent inventor based in Belo Horizonte, Brazil. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines and recombinant viruses. With a total of 2 patents, Gazzinelli's work has the potential to impact public health and veterinary medicine.
Latest Patents
Gazzinelli's latest patents focus on recombinant influenza viruses and modified Vaccinia Ankara viruses (MVA). The first patent describes a process for constructing these recombinant viruses with genes that encode for the parasite SAGI and SAG2 proteins. This process utilizes homologous recombination techniques and reverse genetics. Additionally, he has developed a vaccine composition that employs these recombinant viruses for immunization against infections caused by the parasite. His second patent pertains to a recombinant vaccine against canine visceral leishmaniasis, which contains the recombinant A2 protein and various adjuvants. This vaccine allows for the distinction between vaccinated and infected animals through conventional ELISA or immunofluorescence tests.
Career Highlights
Gazzinelli has worked at esteemed institutions such as the Federal University of Minas Gerais (Universidade Federal De Minas Gerais - Ufmg) and the Oswaldo Cruz Foundation (Fundacao Oswaldo Cruz). His research has been pivotal in advancing the understanding of infectious diseases and developing effective vaccines.
Collaborations
Throughout his career, Gazzinelli has collaborated with notable colleagues, including Ana Paula Salles Moura Fernandes and Christiane De Freitas Abrantes. These collaborations have enriched his research and contributed to the success of his innovative projects.
Conclusion
Ricardo Tostes Gazzinelli's contributions to the field of biotechnology through his patents and research are noteworthy. His work in developing vaccines and recombinant viruses showcases his commitment to improving health outcomes. Gazzinelli's innovations continue to pave the way for advancements in immunization and disease prevention.